Login / Signup

Expansion of the clinical phenotype of GALE deficiency.

Rebecca MarkovitzNichole OwenLisa Forbes SatterSusan E KirkDonald H MahoneyAlison A BertuchFernando Scaglia
Published in: American journal of medical genetics. Part A (2021)
Congenital disorders of glycosylation are a group of rare monogenic inborn errors of metabolism caused by defective glycoprotein and glycolipid glycan synthesis and attachment. Here, we present a patient with galactose epimerase deficiency, also known as GALE deficiency, accompanied by pancytopenia and immune dysregulation. She was first identified by an abnormal newborn screen for galactosemia with subsequent genetic evaluation due to pancytopenia and immune dysregulation. The evaluation ultimately revealed that her known diagnosis of GALE deficiency was the cause of her hematologic and immune abnormalities. These findings further expand the clinical spectrum of disease of congenital disorders of glycosylation.
Keyphrases
  • replacement therapy
  • case report
  • high throughput
  • patient safety
  • emergency department
  • single cell
  • smoking cessation
  • quality improvement